The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status

Table 2 Body mass index and medications in patients participated in two groups receiving high and low doses of vitamin D in the beginning and the end of the study *

Variables	Time of the study		P-value^a
Variables	Beginning of study	End of study	P-value^a
Body mass index (kg/m²)
High dose group	24.29 ± 3.61	24.69 ± 3.34	0.087
Low dose group	25.56 ± 4.27	25.69 ± 4.39	0.192
P-value^b	0.284	0.382
Dose of Azathioprine (mg/day)
High dose group	87.50 ± 25	87.50 ± 25	1
Low dose group	83.33 ± 35.35	83.33 ± 35.55	1
P-value^b	0.837	0.837
Dose of Corticosteroid (mg/day)
High dose group	2.5 ± 7.3	0.9 ± 2.5	0.16
Low dose group	0.2 ± 1.0	0	0.32
P-value^b	0.16	0.10
Dose of Mesalamine (mg/day)
High dose group	2473.68 ± 1123.90	2450 ± 1099.04	0.331
Low dose group	2523.81 ± 872.87	2523.81 ± 872.87	0.696
P-value^b	0.875	0.813

ISSN: 1475-2891